CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

NCT02362165 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Cyclophosphamide
DRUG: Bortezomib
DRUG: Dexamethasone
DRUG: Doxorubicin

Sponsor

Sun Yat-sen University